Understanding PK/PD.
Burns Trauma and Critical Care Research Centre, School of Medicine, Royal Brisbane and Women's Hospital, The University of Queensland, Level 3 Ned Hanlon Building, Butterfield St, Brisbane, QLD, 4029, Australia. j.roberts2@uq.edu.au.|Department of Intensive Care Medicine, The Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.|Department of Pharmacy, The Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.
Jason A
JA
Roberts
Department of Intensive Care, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium.
Fabio Silvio
FS
Taccone
Burns Trauma and Critical Care Research Centre, School of Medicine, Royal Brisbane and Women's Hospital, The University of Queensland, Level 3 Ned Hanlon Building, Butterfield St, Brisbane, QLD, 4029, Australia.|Department of Intensive Care Medicine, The Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.|Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
Jeffrey
J
Lipman
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics; D016638:Critical Illness; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010599:Pharmacokinetics
D000900:Anti-Bacterial Agents